PRKDC and glioblastoma: Using a unique glioblastoma cell model system, M059J with deficient DNA-PK, while M059K with normal DNA-PK, we demonstrate in vitro that MYT1L-overexpressing cells show non-oncogene addiction to DNA-PK.